Discovery of AI-2 Quorum Sensing Inhibitors Targeting the LsrK/HPr Protein-Protein Interaction Site by Molecular Dynamics Simulation, Virtual Screening, and Bioassay Evaluation

被引:3
|
作者
Xu, Yijie [1 ,2 ]
Zeng, Chunlan [2 ]
Wen, Huiqi [3 ]
Shi, Qianqian [1 ,2 ]
Zhao, Xu [4 ]
Meng, Qingbin [2 ]
Li, Xingzhou [1 ,2 ]
Xiao, Junhai [1 ,2 ]
机构
[1] Beijing Inst Pharmacol & Toxicol, Natl Engn Res Ctr Strateg Drugs, Beijing 100850, Peoples R China
[2] Beijing Inst Pharmacol & Toxicol, State Key Lab Toxicol & Med Countermeasures, Beijing 100850, Peoples R China
[3] Acad Mil Med Sci, Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China
[4] Chinese Peoples Liberat Army Gen Hosp, Med Ctr 5, Dept Hepatol, Beijing 100039, Peoples R China
关键词
AI-2; quorum sensing; antibacterial agents; LsrK; virtual screening; molecular dynamics; quorum sensing inhibitors; HPr; SALMONELLA-TYPHIMURIUM; SIGNAL; COMMUNICATION; FAMILY; PHOSPHORYLATION; EXPRESSION; LASR; AL-2; HPR;
D O I
10.3390/ph16050737
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Quorum sensing (QS) is a cell-to-cell communication mechanism that regulates bacterial pathogenicity, biofilm formation, and antibiotic sensitivity. Among the identified quorum sensing, AI-2 QS exists in both Gram-negative and Gram-positive bacteria and is responsible for interspecies communication. Recent studies have highlighted the connection between the phosphotransferase system (PTS) and AI-2 QS, with this link being associated with protein-protein interaction (PPI) between HPr and LsrK. Here, we first discovered several AI-2 QSIs targeting the LsrK/HPr PPI site through molecular dynamics (MD) simulation, virtual screening, and bioassay evaluation. Of the 62 compounds purchased, eight compounds demonstrated significant inhibition in LsrK-based assays and AI-2 QS interference assays. Surface plasmon resonance (SPR) analysis confirmed that the hit compound 4171-0375 specifically bound to the LsrK-N protein (HPr binding domain, KD = 2.51 x 10(-5) M), and therefore the LsrK/HPr PPI site. The structure-activity relationships (SARs) emphasized the importance of hydrophobic interactions with the hydrophobic pocket and hydrogen bonds or salt bridges with key residues of LsrK for LsrK/HPr PPI inhibitors. These new AI-2 QSIs, especially 4171-0375, exhibited novel structures, significant LsrK inhibition, and were suitable for structural modification to search for more effective AI-2 QSIs.
引用
收藏
页数:16
相关论文
共 43 条
  • [31] Discovery of Ubiquitin-Specific Protease 7 (USP7) Inhibitors with Novel Scaffold Structures by Virtual Screening, Molecular Dynamics Simulation, and Biological Evaluation
    Liu, Shengjie
    Zhou, Xinyu
    Li, Minglei
    Zhao, Wenfeng
    Zhou, Shuxi
    Cheng, Keguang
    Xu, Qinglong
    Chen, Caiping
    Wen, Xiaoan
    Sun, Hongbin
    Yuan, Haoliang
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2020, 60 (06) : 3255 - 3264
  • [32] Structure-based virtual screening, molecular dynamics simulation and MM-PBSA toward identifying the inhibitors for two-component regulatory system protein NarL of Mycobacterium Tuberculosis
    Kumar, Niranjan
    Srivastava, Rakesh
    Prakash, Amresh
    Lynn, Andrew. M.
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2020, 38 (11) : 3396 - 3410
  • [33] Discovery of potent inhibitors for interleukin-2-inducible T-cell kinase: structure-based virtual screening and molecular dynamics simulation approaches
    Chandrasekaran Meganathan
    Sugunadevi Sakkiah
    Yuno Lee
    Jayavelu Venkat Narayanan
    Keun Woo Lee
    Journal of Molecular Modeling, 2013, 19 : 715 - 726
  • [34] Discovery of potent inhibitors for interleukin-2-inducible T-cell kinase: structure-based virtual screening and molecular dynamics simulation approaches
    Meganathan, Chandrasekaran
    Sakkiah, Sugunadevi
    Lee, Yuno
    Narayanan, Jayavelu Venkat
    Lee, Keun Woo
    JOURNAL OF MOLECULAR MODELING, 2013, 19 (02) : 715 - 726
  • [35] Discovery of Some Heterocyclic Molecules as Bone Morphogenetic Protein 2 (BMP-2)-Inducible Kinase Inhibitors: Virtual Screening, ADME Properties, and Molecular Docking Simulations
    Belal, Amany
    Elkady, Hazem
    Al-Karmalawy, Ahmed A.
    Amin, Ali H.
    Ghoneim, Mohammed M.
    El-Sherbiny, Mohamed
    Al-Serwi, Rasha Hamed
    Abdou, Mohamed Attia
    Ibrahim, Mona H.
    Mehany, Ahmed B. M.
    MOLECULES, 2022, 27 (17):
  • [36] Discovery of dual S-RBD/NRP1-targeting peptides: structure-based virtual screening, synthesis, biological evaluation, and molecular dynamics simulation studies
    Hu, Chunfang
    Guo, Ting
    Zou, Yunting
    Gao, Junyi
    Gao, Yi
    Niu, Miaomiao
    Xia, Yang
    Shen, Xiaozhou
    Li, Jindong
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2023, 38 (01)
  • [37] In silico targeting of non-structural 4B protein from dengue virus 4 with spiropyrazolopyridone: study of molecular dynamics simulation, ADMET and virtual screening
    Hussain W.
    Qaddir I.
    Mahmood S.
    Rasool N.
    VirusDisease, 2018, 29 (2) : 147 - 156
  • [38] Computational design of new protein kinase 2 inhibitors for the treatment of inflammatory diseases using QSAR, pharmacophore-structure-based virtual screening, and molecular dynamics
    Josiane V. Cruz
    Rodolfo B. Serafim
    Gabriel M. da Silva
    Silvana Giuliatti
    Joaquín M. C. Rosa
    Moysés F. Araújo Neto
    Franco H. A. Leite
    Carlton A. Taft
    Carlos H. T. P. da Silva
    Cleydson B. R. Santos
    Journal of Molecular Modeling, 2018, 24
  • [39] Computational design of new protein kinase 2 inhibitors for the treatment of inflammatory diseases using QSAR, pharmacophore-structure-based virtual screening, and molecular dynamics
    Cruz, Josiane, V
    Serafim, Rodolfo B.
    da Silva, Gabriel M.
    Giuliatti, Silvana
    Rosa, Joaquin M. C.
    Araujo Neto, Moyses F.
    Leite, Franco H. A.
    Taft, Carlton A.
    da Silva, Carlos H. T. P.
    Santos, Cleydson B. R.
    JOURNAL OF MOLECULAR MODELING, 2018, 24 (09)
  • [40] Novel dual-targeting inhibitors of NSD2 and HDAC2 for the treatment of liver cancer: structure-based virtual screening, molecular dynamics simulation, and in vitro and in vivo biological activity evaluations
    Jin, Xing
    Wang, Yuting
    Chen, Jing
    Niu, Miaomiao
    Yang, Yang
    Zhang, Qiaoxuan
    Bao, Guangyu
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2024, 39 (01)